^Vatsis KP, Weber WW, Bell DA, Dupret JM, Evans DA, Grant DM, Hein DW, Lin HJ, Meyer UA, Relling MV. Nomenclature for N-acetyltransferases. Pharmacogenetics. February 1995, 5 (1): 1–17. PMID 7773298. doi:10.1097/00008571-199502000-00001.
Windmill KF, McKinnon RA, Zhu X; et al. The role of xenobiotic metabolizing enzymes in arylamine toxicity and carcinogenesis: functional and localization studies.. Mutat. Res. 1997, 376 (1-2): 153–60. PMID 9202751. doi:10.1016/S0027-5107(97)00038-9. 引文格式1维护:显式使用等标签 (link)
Lan Q, Rothman N, Chow WH; et al. No apparent association between NAT1 and NAT2 genotypes and risk of stomach cancer.. Cancer Epidemiol. Biomarkers Prev. 2003, 12 (4): 384–6. PMID 12692115. 引文格式1维护:显式使用等标签 (link)
Ochs-Balcom HM, Wiesner G, Elston RC. A meta-analysis of the association of N-acetyltransferase 2 gene (NAT2) variants with breast cancer.. Am. J. Epidemiol. 2007, 166 (3): 246–54. PMID 17535831. doi:10.1093/aje/kwm066.
Sanderson S, Salanti G, Higgins J. Joint effects of the N-acetyltransferase 1 and 2 (NAT1 and NAT2) genes and smoking on bladder carcinogenesis: a literature-based systematic HuGE review and evidence synthesis.. Am. J. Epidemiol. 2007, 166 (7): 741–51. PMID 17675654. doi:10.1093/aje/kwm167.